Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amarin Corp ADR
(NQ:
AMRN
)
0.5820
-0.0080 (-1.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amarin Corp ADR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Gainers
Via
Benzinga
Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
November 07, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin (AMRN) Q3 2022 Earnings Call Transcript
October 27, 2022
AMRN earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Amarin Corp: Q3 Earnings Insights
October 27, 2022
Amarin Corp (NASDAQ:AMRN) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
November 07, 2022
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Via
Benzinga
Amarin Corp Earnings Perspective: Return On Capital Employed
October 31, 2022
According to data from Benzinga Pro, during Q3, Amarin Corp's (NASDAQ:AMRN) reported sales totaled $89.88 million. Despite a 92.65% increase in earnings, the company posted a loss of $5.14 million.
Via
Benzinga
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
October 27, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Touts Positive Data For Its Heart Disease Drug In Current/Former Smokers
August 29, 2022
Via
Benzinga
Amarin Corp Earnings Perspective: Return On Capital Employed
August 08, 2022
Via
Benzinga
Amarin Still Suspends FY22 Guidance On Generic Challenges
August 03, 2022
Via
Benzinga
Earnings Preview For Amarin Corp
October 26, 2022
Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that Amarin Corp...
Via
Benzinga
Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors
October 20, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022
October 20, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Board of Directors Issues Statement in Response to Sarissa
October 11, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Corp: Q2 Earnings Insights
August 03, 2022
Amarin Corp (NASDAQ:AMRN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Sarissa Capital Has Commenced the Process to Call a Special Meeting of Amarin Shareholders to Remove and Replace Certain Board Members
October 11, 2022
From
Sarissa Capital Management LP
Via
Business Wire
3 Biotech Stocks Gaining Momentum
September 12, 2022
The headlines have been particularly good for a trio of small cap biotechs and it appears the momentum may have staying power.
Via
MarketBeat
MarketBeat: Week in Review 8/22 - 8/26
August 27, 2022
The markets are selling on news that interest rate hikes will continue past September. But here are some of the other stories for investors to follow this week
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Amarin's New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes
August 26, 2022
New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes...
Via
Benzinga
7 F-Rated Growth Stocks to Sell Before Q4
August 25, 2022
Challenging market conditions make these growth stocks to sell a detriment to your portfolio if you don't dump them before Q4.
Via
InvestorPlace
Are Ocugen or Amarin Good Penny Stocks to Buy?
August 24, 2022
This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing.
Via
MarketBeat
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
August 23, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 22, 2022
Via
Benzinga
Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session
August 22, 2022
Losers
Via
Benzinga
AMC Entertainment, Pharvaris And Some Other Big Stocks Moving Lower On Monday
August 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 19, 2022
Gainers
Via
Benzinga
Does Amarin Deserve a Spot in Your Portfolio after Earnings ?
August 04, 2022
Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio.
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
August 03, 2022
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.
Via
Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
July 01, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.